Skip to main content

Easy-to-use diagnostic tool for the killing efficacy of antibiotics on clinical isolates

Project description

A rapid test for bacterial sensitivity against antibiotics

To efficiently tackle clinical bacteria isolates with antibiotics, a disk diffusion assay is usually employed, which determines the minimum inhibitory concentration. However, this approach cannot distinguish between bactericidal drugs and those that only stop the growth of bacteria. Given that bacteria can develop tolerance to antibiotic treatment, there is a need for an assay to measure the survival of bacteria under antibiotics. Towards this goal, the EU-funded SurviDisk project proposes to develop a single easy-to-use low-cost assay on a disk and validate it against clinical isolates. Routine implementation of SurviDisk is expected to optimise antibiotic treatment and reduce hospitalisation times.

Host institution

THE HEBREW UNIVERSITY OF JERUSALEM
Net EU contribution
€ 150 000,00
Address
Edmond J Safra Campus Givat Ram
91904 Jerusalem
Israel

See on map

Activity type
Higher or Secondary Education Establishments
Other funding
No data

Beneficiaries (1)

THE HEBREW UNIVERSITY OF JERUSALEM
Israel
Net EU contribution
€ 150 000,00
Address
Edmond J Safra Campus Givat Ram
91904 Jerusalem

See on map

Activity type
Higher or Secondary Education Establishments
Other funding
No data